Deutsche Bank Initiates Coverage On Waters with Hold Rating, Announces Price Target of $350
Deutsche Bank analyst Justin Bowers initiates coverage on Waters (NYSE:WAT) with a Hold rating and announces Price Target of $350.
Stifel Initiates Coverage On Travere Therapeutics with Hold Rating, Announces Price Target of $22
Stifel analyst Alex Thompson initiates coverage on Travere Therapeutics (NASDAQ:TVTX) with a Hold rating and announces Price Target of $22.
UBS Initiates Coverage On Bloom Energy with Buy Rating, Announces Price Target of $35
UBS analyst Manav Gupta initiates coverage on Bloom Energy (NYSE:BE) with a Buy rating and announces Price Target of $35.
UBS Initiates Coverage On FuelCell Energy with Neutral Rating, Announces Price Target of $3.85
UBS analyst Manav Gupta initiates coverage on FuelCell Energy (NASDAQ:FCEL) with a Neutral rating and announces Price Target of $3.85.
UBS Initiates Coverage On Aemetis with Neutral Rating, Announces Price Target of $4.25
UBS analyst Manav Gupta initiates coverage on Aemetis (NASDAQ:AMTX) with a Neutral rating and announces Price Target of $4.25.
Wolfe Research Initiates Coverage On SunPower with Peer Perform Rating
Wolfe Research analyst Steve Fleishman initiates coverage on SunPower (NASDAQ:SPWR) with a Peer Perform rating.
Citigroup Initiates Coverage On Larimar Therapeutics with Neutral Rating, Announces Price Target of $4
Citigroup analyst Samantha Semenkow initiates coverage on Larimar Therapeutics (NASDAQ:LRMR) with a Neutral rating and announces Price Target of $4.
Citigroup Initiates Coverage On Sensei Biotherapeutics with Buy Rating, Announces Price Target of $6
Citigroup analyst Samantha Semenkow initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating and announces Price Target of $6.
Citigroup Initiates Coverage On Editas Medicine with Neutral Rating, Announces Price Target of $11
Citigroup analyst Samantha Semenkow initiates coverage on Editas Medicine (NASDAQ:EDIT) with a Neutral rating and announces Price Target of $11.
Citigroup Assumes CarGurus at Neutral, Announces Price Target of $14
Citigroup analyst Ronald Josey assumes CarGurus (NASDAQ:CARG) with a Neutral rating and announces Price Target of $14.